Carmen
De Mendoza Fernandez
Investigadora en el periodo 2019-2022
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (6)
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
2017
-
Antiretroviral treatment of HIV-2 infection
Future Virology, Vol. 12, Núm. 8, pp. 461-472
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
2007
-
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance
Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 4, pp. 698-704
2005
-
Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1
Clinical Infectious Diseases, Vol. 41, Núm. 2, pp. 227-232
-
Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain
Clinical Infectious Diseases, Vol. 41, Núm. 9, pp. 1350-1354